Literature DB >> 6246640

Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphy.

J T Willerson, R W Parkey, F J Bonte, S E Lewis, J Corbett, L M Buja.   

Abstract

99mTc-PYP myocardial scintigrams represent a means to detect and localize acute myocardial necrosis. These scintigrams are expected to be abnormal with acute myocardial infarcts of at least 3 grams in weight if serial imaging is utilized and proper attention to technique is provided. Any etiology of myocardial necrosis may produce abnormal 99mTc-PYP scintigrams if the damage is relatively localized and includes at least 3 grams of tissue. It is possible to accurately size acute anterior and anterolateral transmural myocardial infarcts using area or 2 dimensional measurements. Further development in imaging cameras and computer techniques allowing three dimensional reconstruction of myocardial infarcts with this and similar imaging techniques may allow relatively precise quantitation of other types of myocardial infarcts. The "doughnut" and "persistently abnormal" 99mTc-PYP scintigrams appear to have anatomic and prognostic significance at least in subsets of patients studied, but larger numbers of individuals need to be evaluated before final conclusions regarding their ultimate prognostic significance can be reached.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246640     DOI: 10.1016/s0001-2998(80)80029-8

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  11 in total

Review 1.  Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review.

Authors:  Adam Castaño; Sabahat Bokhari; Thomas H Brannagan; Julia Wynn; Mathew S Maurer
Journal:  Amyloid       Date:  2011-12-08       Impact factor: 7.141

2.  Evaluation of kidney grafts with 99mTc-methylene diphosphonate within 36 hours after transplantation: a marker of ischemic damage.

Authors:  H S Thomsen; H Løkkegaard; O Munck
Journal:  Eur J Nucl Med       Date:  1984

3.  Infarct avid imaging study in the radionuclide diagnosis of acute myocardial infarction.

Authors:  R L van Heertum
Journal:  Bull N Y Acad Med       Date:  1981-11

Review 4.  Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.

Authors:  Wengen Chen; Van-Khue Ton; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2018-03-08       Impact factor: 2.931

5.  Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy.

Authors:  Claudio Rapezzi; Candida Cristina Quarta; Pier Luigi Guidalotti; Simone Longhi; Cinzia Pettinato; Ornella Leone; Alessandra Ferlini; Fabrizio Salvi; Pamela Gallo; Christian Gagliardi; Angelo Branzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-11       Impact factor: 9.236

6.  A patient with cardiac amyloidosis presenting a rapid increase in technetium-99m-hydroxymethylene diphosphonate accumulation.

Authors:  T Kobayashi; M Sekiya; Y Fujiwara; T Sumimoto; H Matsuoka; M Hamada; K Hiwada
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

7.  Myocardial infarction related to coronary artery bypass graft surgery.

Authors:  C G McGregor; A L Muir; A F Smith; H C Miller; W J Hannan; E W Cameron; D J Wheatley
Journal:  Br Heart J       Date:  1984-04

8.  Evaluation of renal ischemia with 99mTc-pyrophosphate.

Authors:  H S Thomsen; A Taylor
Journal:  Eur J Nucl Med       Date:  1982

9.  Emission tomography with 99mTc-pyrophosphate in the diagnosis of acute myocardial infarction.

Authors:  L Pöyhönen; A Uusitalo; A Virjo
Journal:  Eur J Nucl Med       Date:  1985

10.  Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis.

Authors:  Claudio Rapezzi; Christian Gagliardi; Agnese Milandri
Journal:  J Nucl Cardiol       Date:  2018-02-22       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.